Robert Besthof Nrx Pharmaceuticals, Inc. (NRXP) insider trading activity

NRXP Quotes by TradingView

Robert Besthof is Interim CEO of NRX Pharmaceuticals, Inc.. Currently has a direct ownership of 23,710 shares of NRXP, which is worth approximately $35,802. The most recent transaction as insider was on Sep 15, 2021, when has been sold 40,000 shares (Common Stock) at a price of $11.76 per share, resulting in proceeds of $470,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.7K
0% 3M change
0% 12M change
Total Value Held $35,802

Robert Besthof Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 15 2021
SELL
Open market or private sale
$470,400 $11.76 p/Share
40,000 Reduced 62.78%
23,710 Common Stock
Aug 16 2021
BUY
Exercise of conversion of derivative security
$12,742 $0.2 p/Share
63,710 Added 50.0%
63,710 Common Stock
RB

Robert Besthof

Interim CEO
Wilmington, DE

Track Institutional and Insider Activities on NRXP

Follow NRX Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRXP shares.

Notify only if

Insider Trading

Get notified when an Nrx Pharmaceuticals, Inc. insider buys or sells NRXP shares.

Notify only if

News

Receive news related to NRX Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRXP